CDLX

Communication Services

Cardlytics, Inc. · Advertising Agencies · $60M

UQS Score — Balanced Preset
41.9
Average

Cardlytics, Inc. scores 41.9/100 using the Balanced preset.

23.0
Quality
35%
28.0
Moat
30%
18.1
Growth
20%
70.6
Risk
15%

CDLX — Key Takeaways

✅ Strengths

Cardlytics, Inc. shows conservative financial structure with manageable risk
Cardlytics, Inc. shows attractive valuation relative to fundamentals

⚠️ Areas of Concern

Cardlytics, Inc. has below-average profitability metrics
Cardlytics, Inc. has limited growth momentum
Cardlytics, Inc. has limited competitive moat

CDLX — Score History

35404550Apr 2Apr 3Apr 4Apr 5Apr 6Apr 7Apr 8
DateUQSQualityMoatGrowthRiskValueChange
Apr 8, 202641.923.028.018.170.6100.00.0
Apr 7, 202641.922.728.018.170.6100.0-0.1
Apr 6, 202642.023.228.018.170.6100.00.0
Apr 5, 202642.023.228.018.170.6100.00.0
Apr 4, 202642.023.228.018.170.6100.00.0
Apr 3, 202642.023.228.018.170.6100.0-0.4
Apr 2, 202642.424.928.018.170.6100.0

CDLX — Pillar Breakdown

Quality

23.0/100 (25%)

Cardlytics, Inc. currently shows below-average quality metrics, suggesting challenges with profitability.

Capital Efficiency (ROIC)Weak

How effectively capital is deployed to generate returns.

Return on EquityWeak

Profitability relative to shareholders' equity.

Operating ProfitabilityWeak

Ability to convert revenue into operating profit.

Net ProfitabilityWeak

Bottom-line profit as a share of revenue.

Gross Profit / AssetsModerate

Asset productivity — how much gross profit each dollar of assets generates.

Cash GenerationStrong

Free cash flow relative to market value.

Growth

18.1/100 (20%)

Cardlytics, Inc. faces growth headwinds with declining or stagnant revenue trends.

Recent Revenue TrendWeak

Revenue trajectory over the last twelve months.

3Y Revenue CAGRWeak

Compound annual revenue growth rate over 3 years.

EPS GrowthStrong

Year-over-year earnings per share growth.

Forward Revenue OutlookWeak

Analyst consensus for future revenue growth.

Risk

70.6/100 (15%)

Cardlytics, Inc. maintains a reasonable risk profile with manageable debt levels.

Financial LeverageStrong

Debt levels relative to earnings capacity.

Debt/EquityStrong

Total debt relative to shareholder equity.

Current RatioModerate

Short-term liquidity — ability to pay near-term obligations.

Interest CoverageWeak

Earnings capacity relative to interest payments.

Valuation

100.0/100 (15%)

Cardlytics, Inc. appears attractively valued relative to its earnings, cash flows, and sector peers.

Price to Free Cash FlowStrong

How many years of FCF the market cap represents.

Moat

28/100 (30%)

Cardlytics, Inc. operates in a highly competitive environment with limited sustainable advantages. The Moat pillar evaluates competitive advantages across five dimensions: Switching Costs, Network Effects, Cost Advantage, Intangible Assets, and Scale & Ecosystem. Sign in to customize moat ratings for CDLX.

Score Composition

Quality
23.0×25%5.8
Growth
18.1×20%3.6
Risk
70.6×15%10.6
Valuation
100.0×15%15.0
Moat
28.0×30%8.4
Total
41.9Average

Unlock Full CDLX Analysis

Sign in to access detailed financial metrics, interactive price charts, custom pillar weights, 6 investor presets, and watchlist tracking.

✓ Detailed ratios✓ Price chart✓ Custom moat ratings✓ 6 investor presets✓ Watchlist
Analyze CDLX in Detail →

More Stock Analysis

How is the CDLX UQS Score Calculated?

The UQS (Unified Quality Score) for Cardlytics, Inc. is calculated using a proprietary 5-pillar framework with 25 financial metrics. Each pillar evaluates a different dimension on a 0–100 scale, then combines into a single weighted score. Scoring thresholds are calibrated per sector.

Quality (25%) measures profitability and capital efficiency — ROIC, ROE, margins, GP/Assets, and FCF Yield.

Moat (25%) assesses Cardlytics, Inc.'s competitive advantages across switching costs, network effects, cost advantages, intangible assets, and ecosystem scale.

Growth (20%) tracks revenue trajectory and earnings momentum, combining historical results with analyst forward estimates.

Risk (15%) is inversely scored — lower leverage and strong balance sheet health result in higher scores.

Valuation (15%) measures whether Cardlytics, Inc. is fairly priced using earnings yield, price-to-FCF, PEG ratio, and EV/EBITDA relative to sector peers.

Six investor-inspired presets are available, each with different pillar weights: Balanced, Buffett, Munger, Lynch, Cathie Wood, and Graham. The public score shown here uses the Balanced preset. Learn more in our FAQ.